Background/Objectives: The hepatic prognosis of long-term home total parenteral nutrition (TPN)-dependent children is poorly documented. The objective was to study outcome data in home TPN-dependent children and to describe precisely their liver biopsies in the attempt to analyze risk factors for biochemical and histological hepatic abnormalities. Subjects/Methods: Medical records of 42 children receiving home TPN for more than 2 years between January 1998 and December 2007 in a single approved home total parenteral center were reviewed. Hepatic biochemical abnormalities were analyzed. Hepatic biopsies were classified by two independent pathologists. Results: Duration of TPN was 7.9 ± 0.8 years (mean ± s.e.m.), with an average age at onset of 1.5 ± 0.5 years. A total of 24 patients (57%) developed biochemical liver abnormalities in an average of 2.9±0.4 years after starting TPN. Risk factors for biochemical abnormalities were younger age at TPN commencement, longer duration of TPN, higher rate of catheter-related infections and higher volume and energy content of TPN. Liver biopsies were carried out in 43% of patients (mean age 3.2±0.9 years). Almost all patients had fibrosis (94%). Risk factors were dependent on each histological abnormality: fibrosis was significantly associated with a shorter length of bowel and a longer duration of TPN; cholestasis correlated with a lower percentage of total parenteral energy intake due to lipids; and steatosis had no risk factor identified. Conclusion: Our study reports a high rate of histological liver abnormalities and analyzes risk factors in children who underwent very long-term home TPN.
Introduction
For children depending on total parenteral nutrition (TPN), home TPN is an alternative to prolonged hospitalization. However, a long period of TPN can lead to severe complications. Among them, chronic abnormalities in liver biochemistries are frequent in adult and children, ranging from 15 to 85% (Clarke et al., 1991; Colomb et al., 1992; Messing et al., 1992; Quigley et al., 1993; Angelico and Della Guardia, 2000; Knafelz et al., 2003; Kelly, 2006; Colomb et al., 2007) .
Chronic PN-associated liver disease (PNALD) can lead to cholestasis and steatosis, as well as fibrosis and cirrhosis. However, the lack of an accurate and standardized histological classification is an obstacle to compare studies. Many risk factors of PNALD have been identified (Ito and Shils, 1991; Beath et al., 1996; Colomb et al., 2000; Fitzgibbons et al., 2010) . However, in children, data are fewer than in large adult cohorts and risk factors may be different. Furthermore, the duration of TPN varies widely among patients, confusing the impact of different factors. In addition, data on very long-term TPN in children are lacking. Finally, the relation between risk factors and specific histological abnormalities (i.e. fibrosis, cholestasis and steatosis) are poorly documented. Therefore, the aims of this study were to analyze retrospectively outcome data in children receiving home TPN for more than 2 years and to describe accurately the liver lesions in an attempt to analyze risk factors for PNALD hepatic biochemical and histological abnormalities.
Patients and methods
Data were aggregated retrospectively from medical records over a 10-year period, from January 1998 to December 2007. We included children depending on TPN for more than 2 years, enrolled in long-term TPN programs of a single approved pediatric home TPN center in a French university teaching hospital. Children with liver-disease diagnosed before initiation of TPN or identified as unrelated to TPN (i.e. inborn liver disease, acquired toxic or viral liver disease) were excluded.
If TPN was essential to maintain growth and nutritional status, then home TPN was prescribed. Parents were taught home infusion during an average of 2-3 weeks, as previously described (Puntis, 1995) . Follow-up included a 24-h telephone hotline number for emergencies and regular outpatient follow-up visits to adapt the composition and volume of the nutrient solution to meet the child's requirement and to detect the occurrence of PN-associated liver disease complications. The goal was to progressively decrease the number of nightly infusions, if intestinal function improved. The composition of the TPN (i.e. amino acids, lipid emulsion, trace elements and vitamins) varied during the 10 years of the study.
Variables contributing to the development of PNALD were collected from the medical charts and included: demographical characteristics (age, sex, length of gestation, birth weight and height); the primary diagnosis including the etiology of short bowel syndrome (SBS); the length of remaining small bowel and conservation of ileocecal valve and/or colon; the age at TPN commencement and duration of TPN; the reason for TPN discontinuation; the numbers of days per week of TPN infusion and the duration in hours per day. Other factors evaluated included; the type of bacteria and the number of catheter-related infections defined as episodes of fever with clinical and biological parameters of infection (i.e. increased plasma concentration of C-reactive protein and polynuclear); positive blood cultures from the catheter and peripheral vein for the same pathogen or 41 positive blood culture for the same pathogen, effectiveness of antibiotic therapy; the presence of oral or enteral nutrition; and the cause of death. Furthermore, the home TPN regimen was analyzed to assess the mean daily volume and parenteral energy intake, the amounts of lipid, dextrose and protein expressed in g/kg of body weight per day, and the proportion of lipid and dextrose expressed as percentage of parenteral energy intake.
Criteria for PNALD were abnormalities in liver biochemistries lasting longer than 2 months including: hepatocellular injury (plasma alanine transaminase concentrations 1.5 times above the upper limit of normal) and cholestasis (bilirubin or alkaline phosphatase and g-glutamyl transpeptidase plasma concentrations 1.5 times above the upper limit of normal). Biochemical abnormalities were classified as cytolysis alone, cholestasis alone or both, if both cytolysis and cholestasis were present.
The first liver biopsy (LB) was performed, if liver biochemistries or clinical hepatic abnormalities persisted for more than 6 months; or rarely, if abdominal surgery was necessary (cholecystectomy, for example). Another biopsy was carried out, if abnormalities on liver biochemistries worsened and latter from any sepsis or further risk factor. Formalinfixed LB specimens were stained with hematoxylin-eosinsaffron, trichrome, periodic acid-Schiff and Perls. In addition, oil-red staining was performed on frozen biopsy specimens when they were available. All LBs were analyzed and scored retrospectively and independently by two pathologists using five criteria as described in Table 1 in attempt to quantify fibrosis, cholestasis and steatosis. If disagreements existed between the two analyses, the final reported result was based on a third analysis carried out by both pathologists together.
Statistical analysis First, we described the patients' characteristics and their biochemical and histological hepatic abnormalities. Thereafter, to analyze risk factors of home PNALD abnormalities, patients were divided into two groups depending on to compare the observed frequencies between the independently defined groups. Statistical significance was defined as a P-value o0.05.
Results

Description of population
A total of 42 patients with very long-term TPN (42 years) were included (see Table 2 ). The male/female sex ratio was 1.2. Half were premature (o37 weeks gestational age) and 25% were less than 31 weeks gestational age. Indications for home TPN were mainly primary digestive disease (n ¼ 38, 90%): SBS, chronic intestinal pseudo-obstruction, intractable diarrhea or inflammatory bowel disease. The largest subgroup included children with SBS, primarily neonatal in origin: atresia (n ¼ 9, 39%), enterocolitis (n ¼ 8, 35%) or volvulus (n ¼ 3, 13%). Among the 60% of children with SBS, the length of remaining small bowel was less than 50 cm in 17 (41%), between 51 cm and 100 cm in 5 (12%) and between 101 cm and 150 cm in 3 (7%) patients. The ileocecal valve was intact in 60% of children.
Home TPN duration
The overall home TPN mean duration was long, almost 8 years. Most patients (n ¼ 33, 78.6%) began TPN before the age of 1 year with a median age during neonatal period. The age at TPN beginning, as well as the duration of home TPN, depended on the indication ( Figure 1 ). In all, 69% of patients (n ¼ 29) had TPN for longer than 4 years and 43% (n ¼ 18) for more than 8 years.
TPN weaning and death
By January 2008, outcome is summarized in Table 2 . Around half of children remained on TPN. Interestingly, nine children (21.4%) were weaned off after 5 years; the longest one was weaned off after 11 years. Almost half of patients (n ¼ 10, 43.5%) with SBS, despite a TPN dependency longer than 2 years, were weaned off TPN; but only 14.3% (n ¼ 1) of those with chronic intestinal pseudo-obstruction or Hirschsprung's disease were weaned off. In all, 15 children (35.7%) were continuing home TPN in our pediatric centre and six others (14.3%) in an adult centre. Three patients (7%) had died: one from his primary disease (AIDS), one just after his intestinal transplantation and the last one just after bone marrow transplantation for immune deficiency. None died from hepatic complications, nor from direct complications of TPN. Three children (7%) underwent isolated intestinal transplantation: one with SBS died in the early postoperative period, as mentioned above, one with Hirschsprung's disease lost an intestinal graft after acute transplant rejection and restarted home TPN, and one with Hirschsprung's disease was weaned off TPN. Liver disease and parenteral nutrition B Peyret et al
Infectious complications
The mean frequency of catheter-related infections was 1.1 ± 0.2 infections/patient/year of TPN, which corresponded to 7.5±1.2 infections/patient. Only four patients (10%) never had septicemia, 12% (n ¼ 5) had a single septic episode and 14% (n ¼ 6) had two episodes. The bacteria most often identified were coagulase-negative Staphylococcus.
Biochemical liver abnormalities and risk factors A total of 24 patients (57%) developed biochemical liver abnormalities after a mean TPN duration of 2.9±0.4 years, as detailed in Table 3 . One-third of patients (n ¼ 14) had the first biochemical disturbance before the age of 1 year. Among patients weaned off TPN, almost all (14/16) normalized their hepatic biochemistry within the 5 years; 2 others normalized in the next 2 years and for the last one we have no information concerning the hepatic biochemistry. Risk factors for biochemical abnormalities are summarized in Table 4 : younger age of TPN commencement (P ¼ 0.032), longer duration of TPN (P ¼ 0.001), higher rate of catheterrelated infections (P ¼ 0.004), higher volume and energy content of TPN (P ¼ 0.002 and P ¼ 0.017 respectively), including a higher glucose rate in TPN (P ¼ 0.01).
In all, 16 patients (38%) had a cholestectomy: 6 (38%) for lithiasis and the others for prevention of lithiasis.
Hepatic histological abnormalities and risk factors
The LB was conducted only in those children who presented with abnormal liver biochemistries for more than 6 months or in the rare child who required abdominal surgery. A total of 43 LBs were performed in 19 patients; 38 were percutaneous needle biopsies and 5 were surgical biopsies (15%). Only 34 were available for retrospective analysis (79%), corresponding to 18 children (43%); the 5 missing LBs were either performed in other hospital or specimen was transferred to other center. LBs were performed after a median of 2.5 years and one-third of LBs were performed during the first year of TPN. Almost all patients had fibrosis (94%), 41% had cholestasis and 41% had steatosis, as detailed in Table 3 . Three patients had a LB during cholestectomy before biochemical abnormalities developed. All these patients had fibrosis (stage 2 or 3) and two also had steatosis.
Risk factors were dependent on each histological abnormality (Table 4) : fibrosis was significantly associated with a shorter length of bowel (P ¼ 0.015) and a longer duration of home TPN (P ¼ 0.049); cholestasis was correlated with a This table describes the number of patients and the duration of total parenteral nutrition depending on the type of hepatic abnormalities. First, the biochemical hepatic abnormalities are classified as cytolysis (ALT increased), cholestasis (bilirubin and/or GGT increased) or both so called mixt (cytolysis and cholestasis). Second, the histological abnormalities are classified as fibrosis, cholestasis and steatosis. The intensity of histological abnormalities is expressed as mild, moderate or severe.
Liver disease and parenteral nutrition B Peyret et al lower percentage of total parenteral energy intakes from lipids (P ¼ 0.025). Steatosis had no risk factor identified in our cohort.
Discussion
Our study describes the evolution of home PNALD in 42 children receiving very long-term parenteral nutrition (average of 9 years and 8 months). We included a series of LBs for 18 children. The histological samples were accurately analyzed retrospectively by two independent pathologists using five histological criteria (Table 1) . In our cohort, only 10% of patients had home TPN for an extra digestive disease. This incidence is lower than other cohorts, in which these etiologies account for around 25% of cases (Ito and Shils, 1991; Kelly, 2006) . This difference could be related to exclusion criteria, as we excluded all children with home TPN durations of less than 2 years and those with initial hepatic insufficiency. On the other hand, SBS resulting from neonatal causes accounted for almost half of patients with digestive disease, in accordance with the other published studies (Colomb et al., 1992 (Colomb et al., , 2000 Diamanti et al., 2007) .
The duration of home TPN in our cohort was especially important; it was almost double the duration of previous pediatric studies (Colomb et al., 1992 Beath et al., 1996; Diamanti et al., 2007 , Fitzgibbons et al., 2010 . We decided to include only children with more than 2 years of home TPN, which correspond to the theoretical duration of intestinal adaptation. Interestingly, 17 children (40.5%) were weaned off TPN after a long duration (5.5 years), which is a crucial point for intestinal transplantation evaluation. The difficulty of weaning off TPN was dependent on the etiology: the children with SBS had a high success rate of stopping TPN after 2 years (43.5%), on the other hand, children with chronic intestinal pseudo-obstruction or Hirschsprung's disease had less chance of TPN weaning after the same 27.2 ± 10.9 11.8 ± 6.7 0.032 0.5 ± 0.5 6.2 ± 5.5 NS 7.5 ± 7.4 1.9 ± 1.2 NS 7.2 ± 6.8 1. 12.4 ± 0.9 14.3 ± 4.2 NS 13.5 ± 2.1 15.0 ± 4.8 NS 13.6 ± 3.6 17.6 ± 5.6 NS 14.7 ± 4.5 15.3 ± 5.8 NS Infections n/patient (mean ± s.e.m.)
3.9 ± 4.9 10.1 ± 8.7 0.004 7.0 ± 9.9 8.5 ± 5.6 NS 8.7 ± 6.0 7.7 ± 5.8 NS 8.5 ± 6.3 7.8 ± 5.0 NS Gram-negative infection, n/patient (mean ± s.e.m.)
1.2 ± 2.0 3.6 ± 4.8 NS 4.0 ± 5.7 2.9 ± 3.5 NS 3.2 ± 3.7 2.8 ± 3.8 NS 3.4 ± 3.9 2.0 ± 2.8 NS Abbreviations: NS, no significant; mo, month. This table details the factors associated with biochemical or histological hepatic abnormalities among the pathology, the parenteral nutrition characteristics, and catheter-related infection. Bold values indicate statistical significance.
duration (14%), as described in previous studies (Colomb et al., 1992; Quiros-Tejeira et al., 2004) . The mortality in our cohort was especially low (7%) compared with similar pediatric groups (16-33%) (Colomb et al., 1992; Angelico and Della Guardia, 2000) . In our study, the long duration of TPN favored a selection of patients with digestive etiologies, which have a better survival rate compared with systemic disease (congenital and acquired immune deficiencies, for example).
Catheter-related septicemia is one of the most frequent complications of TPN. In our study, the incidence of septic episodes was similar to the other studies: 1.1 versus 0.4-1.5 septicemia/child/year of TPN in the previously published data (Colomb et al., 1992; Beath et al., 1996) . Only 10% of our patients never had a catheter-related infection. Negativecoagulase Staphylococcus was the main pathogen responsible for infection (43%), which is also in accordance with previous studies (Beath et al., 1996; Hermans et al., 2007) .
PNALD is another classical complication of TPN. Prevalence of this complication varies from 7.4-84% in the literature, depending on the pathology and the criteria used to define the liver complication (Colomb et al., 1992; Kelly, 1998; Kumpf, 2006) . For this reason, we described precise biochemical and histological hepatic abnormalities. Biochemical impairments were especially frequent in our cohort (57%) compared with the other pediatric studies (15-23%) (Angelico and Della Guardia, 2000; Colomb et al., 2007; Diamanti et al., 2007) ; Diamanti et al., 2003) ; despite oral nutrition for all patients of our cohort, which is a wellknown protective factor against PNALD. Again, the double duration of TPN in our cohort compared with previous published studies may explain this difference. Furthermore, a substantial number of LBs were performed (43% of children), demonstrating a high rate of histological complications: fibrosis was present in almost all children who underwent LB, whereas both cholestasis and steatosis was found in 41% of patients (Table 3 ). This high frequency of fibrosis is in agreement with a recent study: in a cohort of 6.1-month-old children, Fitzgibbons described 89% of hepatic biopsies with fibrosis and 9.6% with cirrhosis despite a shorter duration of TPN (4.7 month vs 2 years) (Fitzgibbons et al., 2010) . In our study, the follow-up of histological abnormalities indicated that steatosis was stable or decreased during the 10-year study period for the majority of patients; cholestasis varied widely depending on the patients, and fibrosis was stable or increased but never decreased (data not shown). At 5 years after TPN discontinuation, almost all patients normalized their hepatic biochemistry, however, we have no histological analysis to confirm a complete normalization. Interestingly, three patients without any biochemical abnormality underwent a systematic LB during cholestectomy. All three had fibrosis (stage 2-3), and two of them had associated steatosis. The same association of fibrosis with normal hepatic biochemical parameters was reported in youngest children: 55% of biopsies with fibrosis and 37% (3/8 patients) with cirrhosis were obtained in patients without evidence of biochemical cholestatis (Fitzgibbons et al., 2010) . These results raise the issue of systematic LB and the place of new techniques such as Fibroscan (de Ledinghen et al., 2007) to monitor very longterm TPN in the attempt to detect infra-biochemical liver complications. Further multicenter trials are needed to answer to this important clinical question.
The pathophysiology of PNALD complications is not yet fully understood. Many risk factors are involved. To our knowledge, this study is the first to analyze independent risk factors for biochemical or histological abnormalities in very long-term TPN and to propose an accurate classification of histological abnormalities (Table 1) . Interestingly, risk factors were different depending on the kind of complication (Table 4 ). For biochemical impairment as reflected by abnormal liver biochemistries, we confirmed some risk factors previously described, such as a young age of TPN initiation, a long duration of TPN, a higher rate of catheterrelated infections, a higher volume and energy content of TPN, and a high glucose rate in TPN (expressed as absolute intake g/kg/d or as in relative amount of % caloric intake) (Candusso et al., 1995; Puntis, 1995; Beath et al., 1996; Kelly, 1998; Quiros-Tejeira et al., 2004; Kumpf, 2006) . Surprisingly, the lipid rate in TPN was not statistically significantly related to biochemical abnormalities as previously described (Cavicchi et al., 2000; Kaufman et al., 2003; Kumpf, 2006; Diamanti et al., 2007; Hermans et al., 2007) . We can argue, first, that during management of our cohort, a high rate of lipids was avoided in accordance with international recommendations (Koletzko et al., 2005) ; second, that a high glucose rate leading to increasing biochemical abnormalities indicates that the carbohydrate-to-lipid ratio is important for preventing hepatic disturbances, as previously reported (Bresson et al., 1989) . With respect to histological risk factors, for steatosis, we didn't find any significant risk factors among those analyzed. In contrast, a more severe fibrosis was associated with a shorter intestinal length, a longer duration of TPN and a higher rate of lipid infusion (P ¼ 0.05). Recently, gestational age at birth was reported to be significantly associated with the degree of liver fibrosis (Fitzgibbons et al., 2010) . Cholestasis was only associated with lipid intake as percentage of total energy. Other classical risk factors, such as prematurity (Kelly, 1998; Kaufman et al., 2003; Quiros-Tejeira et al., 2004; Kumpf, 2006; Robinson and Ehrenkranz, 2008) , intrauterine growth retardation (Robinson and Ehrenkranz, 2008) and resection of the ileocecal valve, were not found in our cohort.
Conclusion
Our study describes a cohort of children with the longest duration of home TPN in the literature and indicates that late weaning off of TPN is possible in almost half of patients. To our knowledge, this is the first study that uses standardized criteria for histological biopsies to analyze the deleterious effect of long-term home TPN in children. It demonstrates a high rate of PN-associated liver disease hepatic complications. However, in our study, even if these children were at high risk, none died of hepatic complications. For the first time, we showed that histological liver injuries were dependent on specific risk factors and we reported their evolution over time. Our study highlights the importance of preventing catheter-related infections and adaptation of the lipid-glucose ratio to decrease hepatic damage. Finally, we raise the issue of systematic LBs to monitor hepatic complications in very long-term TPN.
